More Neurotech International Ltd. news
Neurotech International Ltd.ASX: NTI

Successful Completion of In Vitro Studies

Dec 20, 2020 at 10:59 PM EST · Issued by Neurotech International Ltd.

Filed with ASX · Dec 20, 2020 at 10:59 PM EST

On 6ix: 6ix.com/news/successful-completion-of-in-vitro-studies

Neurotech International Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Neurotech International Ltd. on 6ix

Story so far

  • Further Success with Preliminary In-vitro StudiesNov 30, 2020
  • Neurotech Proceeds to in vitro trials after Positive ResultsSep 7, 2020

Earlier from Neurotech International

  • Further Success with Preliminary In-vitro StudiesNov 29, 2020
  • Voluntary SuspensionNov 26, 2020
  • Interim Results and Capital RaisingNov 1, 2020
  • Response to ASX Price and Volume QueryOct 22, 2020
  • Neurotech Proceeds to in vitro trials after Positive ResultsSep 6, 2020

Later from Neurotech International

  • Neurotech Expands License with Dolce Cann GlobalMar 1, 2021
  • Quarterly Report and Appendix 4CJul 29, 2021
  • Appendix 4E and Annual ReportAug 29, 2021
  • Response to ASX Query LetterOct 13, 2021
  • Application for quotation of securities - NTIJan 24, 2022
All Neurotech International news releases↗

Follow Neurotech International into a list and get an email when it puts out news.

Follow Neurotech International
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer